Speaking with us on Well Said is Dr. Banu Aygun, a Pediatric Hematologist, Oncologist and Professor of Pediatrics at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. She also serves as the Associate Chief of Hematology at Cohen’s Children’s Hospital and the Section Head of Sickle Cell Disease at Cohen Children’s Medical Center. She will be joined by her patient, Juan Carlos Benitez who was part of a landmark clinical trial that led to the FDA approval of a gene therapy for SSD. They will be discussing the ins and outs of SSD as well as the many new promising treatments including recent clinical trials focusing on gene editing.